Replies to post #76399 on Biotech Values

[DewDiligence]

I've seen that provision. I claim that, from a practical standpoint, this is effectively a right of first refusal. VRX gains nothing by forcing the program to sit in limbo awaiting a phase-2b trial that will never be conducted.